Schwarzman Stephen A's Form 4 filing
Imago BioSciences, Inc. (IMGO) · filed Jul 20, 2021
- Accession no.
- 0001567619-21-013733
- Filed
- Jul 20, 2021, 6:05 PM ET
- Trade date
- Jul 20, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market purchases total $2.40M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schwarzman Stephen ACIK 0001070844 | 10% Owner |
| Blackstone Inc.CIK 0001393818 | 10% Owner |
| Blackstone Group Management L.L.C.CIK 0001404071 | 10% Owner |
| Blackstone Holdings I/II GP L.L.C.CIK 0001464695 | 10% Owner |
| Blackstone Holdings II L.P.CIK 0001484870 | 10% Owner |
| Clarus Lifesciences III, L.P.CIK 0001597143 | 10% Owner |
| Clarus Ventures III GP, L.P.CIK 0001620148 | 10% Owner |
| Blackstone Clarus III L.L.C.CIK 0001762202 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 | Common Stock | CConversionAcquired | +1,872,217 | –F1 | – | 1,872,217 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionAcquired | +1,155,689 | –F1 | – | 3,027,906 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionAcquired | +197,131 | –F1 | – | 3,225,037 | Indirect | |
| Jul 20, 2021 | Common Stock | PPurchaseAcquired | +150,000 | $16.00 | +$2,400,000 | 3,375,037 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 | Common Stock | CConversionDisposed | −1,872,217 | $0.00 | $0 | 0 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionDisposed | −1,155,689 | $0.00 | $0 | 0 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionDisposed | −197,131 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each share of the issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) shares of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on July 20, 2021 and had no expiration date.
Referenced by the price of 3 transactions in Table I.
Remarks
CLARUS LIFESCIENCES III, L.P., By: Clarus Ventures III GP, L.P., its GP, By: Blackstone Clarus III, L.L.C., its GP, By: Blackstone Holdings II L.P., its managing member, By: Blackstone Holdings I/II GP L.L.C., its GP, By: /s/ Tabea Hsi, SMD CLARUS VENTURES III GP, L.P., By: Blackstone Clarus III, L.L.C., its GP, By: Blackstone Holdings II L.P., its managing member, By: Blackstone Holdings I/II GP L.L.C., its GP, By: /s/ Tabea Hsi, Title: Senior Managing Director BLACKSTONE CLARUS III L.L.C., By: Blackstone Holdings II L.P., its managing member, By: Blackstone Holdings I/II GP L.L.C., its general partner, By: /s/ Tabea Hsi, Title: Senior Managing Director BLACKSTONE HOLDINGS II L.P., By: Blackstone Holdings I/II GP L.L.C., its general partner, By: /s/ Tabea Hsi, Title: Senior Managing Director BLACKSTONE HOLDINGS I/II GP L.L.C., By: /s/ Tabea Hsi, Title: Senior Managing Director THE BLACKSTONE GROUP INC., By: /s/ Tabea Hsi, Title: Senior Managing Director BLACKSTONE GROUP MANAGEMENT L.L.C., By: /s/ Tabea Hsi, Title: Senior Managing Director /s/ Stephen A. Schwarzman